TED Initiative Receives FDA Qualification of Medical Device Development Tool

March 12, 2019
“We’re committed to providing tools and policies to enable the efficient development of novel technologies that can address significant unmet patient needs. This is especially true when it comes to the development of treatments for traumatic brain injury, where few treatment options exist,” said...

2019 MHSRS Call for Abstracts - 4 Feb to 15 Mar 2019

February 05, 2019
The 2019 Military Health System Research Symposium (MHSRS) Call for Abstracts opens 4 February 2019 and will close on 15 March 2019. This date WILL NOT be extended past 15 March, so please plan accordingly.

Invitation to Neurotrauma Community to Submit Proposals for Candidate Drugs for TRACK-TBI NET Phase 2 Trials

December 20, 2018
TRACK-TBI NET is seeking proposals for candidate pharmacologic agents for Phase 2 TBI clinical trials. Interested parties should submit a Clinical Trial Synopsis by or before January 28, 2019.

With Dangers of Everyday Concussions Revealed, Scientists Race to Find Solutions

By Nina Bai on October 17, 2018
A bump to the head from slipping on the stairs, falling off a skateboard, or running into an open cupboard door has long been seen as a temporary injury, something resolved with a little rest. But a growing body of research suggests that, for some people, even concussions that seem mild can have...

Doctors Fail to Flag Concussion Patients for Critical Follow-Up

By Suzanne Leigh on May 25, 2018
As evidence builds of more long-term effects linked to concussion, a nationwide study led by scientists at UCSF and the University of Southern California has found that more than half of the patients seen at top-level trauma centers may fall off the radar shortly after diagnosis, placing in...

TED Initiative Receives FDA Letter of Support for Biofluid Biomarkers

January 08, 2018
On January 10, 2018, the TED Initiative, along with TRACK-TBI, received an FDA Letter of Support (LOS) to encourage the further study of blood levels of glial fibrillary acidic protein (GFAP), a biomarker of astrocytic injury and ubiquitin carboxyl-terminal hydrolase-L1 (UCH-L1), a biomarker of...

TED Investigators Receive FDA Letter of Support for Neuroimaging Biomarkers

March 17, 2017
The TED Initiative has reached an important milestone in securing an FDA Letter of Support to further explore neuroimaging prognostic biomarkers that may be used to enrich TBI clinical trials with patients who display particular pathoanatomic features that have been associated with poor short to...